Published in Immunology on November 01, 1967
A study of the immunosuppressive activity of methylene dimethane sulphonate (MDMS) in relation to its effectiveness as an anti-tumour agent. Br J Cancer (1972) 0.97
The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82
Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs. Br J Cancer (1994) 0.80
Plaque formation in agar by single antibody-producing cells. Science (1963) 17.94
Myleran in chronic myeloid leukaemia; chemical constitution and biological action. Lancet (1953) 3.27
The localization of x-ray injury to the initial phases of antibody response. J Infect Dis (1953) 2.07
The effect of cytotoxic agents on the production of antibody to T.A.B. vaccine in the mouse. Biochem Pharmacol (1962) 1.80
Relation of primary antigen injection to time of irradiation on antibody production in mice. J Immunol (1958) 1.48
A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON ALLOGENEIC SKIN GRAFT SURVIVAL IN RATS. Bull Johns Hopkins Hosp (1965) 1.46
Effect of uracil mustard and several antitumor drugs on the primary antibody response in rats and mice. J Natl Cancer Inst (1965) 1.41
The role of body fat in limiting the duration of action of thiopental. J Pharmacol Exp Ther (1952) 1.32
A COMPARISON OF THE EFFECTS OF SELECTED CYTOTOXIC AGENTS ON THE PRIMARY AGGLUTININ RESPONSE IN RATS INJECTED WITH SHEEP ERYTHROCYTES. Bull Johns Hopkins Hosp (1964) 1.20
Metabolism of myleran (1:4-dimethanesulphonyloxybutane). Nature (1959) 1.19
EFFECT OF ACTINOMYCIN C ON IMMUNE RESPONSES IN VIVO. Nature (1964) 0.88
The inhibition of hemagglutinin formation in mice by thioguanin. J Immunol (1962) 0.85
The comparative metabolism of Myleran-35S in the rat, mouse and rabbit. Biochem Pharmacol (1960) 0.84
THE BONE-MARROW DEPRESSANT AND ANTITUMOR PROPERTIES IN ANIMALS OF SOME NEW ALKYLATING AGENTS. Cancer (1964) 0.80
A method for testing for synergy with any number of agents. J Infect Dis (1978) 9.52
Immunity to malaria: antigenic variation in chronic infections of Plasmodium knowlesi. Nature (1965) 5.45
Is azathioprine a better immunosuppressive than 6-mercaptopurine? Clin Exp Immunol (1971) 3.47
Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol (1977) 2.89
Assessment of immunity to mycobacterial infection with luciferase reporter constructs. Infect Immun (1999) 2.65
Postoperative depression of the lymphocyte response to phytohaemagglutinin. Lancet (1967) 2.57
Criteria for analyzing interactions between biologically active agents. Adv Cancer Res (1981) 2.49
Immunity to malaria. I. Protection against Plasmodium knowlesi shown by monkeys sensitized with drug-suppressed infections or by dead parasites in Freund's adjuvant. Exp Parasitol (1970) 2.35
Immunity to malaria: the antibody response to antigenic variation by Plasmodium knowlesi. Immunology (1968) 2.30
Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet (1995) 2.29
The expected effect of a combination of agents: the general solution. J Theor Biol (1985) 2.06
Immunity to malaria. II. Serological response of monkeys sensitized by drug-suppressed infection or by dead parasitized cells in Freund's complete adjuvant. Exp Parasitol (1970) 1.86
Inbred mouse strain resistance to Mycobacterium lepraemurium follows the Ity/Lsh pattern. Immunology (1982) 1.83
In vivo biological activity of the components of haematoporphyrin derivative. Br J Cancer (1982) 1.82
Three pathways for trehalose biosynthesis in mycobacteria. Microbiology (2000) 1.73
Immunological aspects of malaria infection. Adv Immunol (1969) 1.70
Contribution of Th1 and Th2 cells to protection and pathology in experimental models of granulomatous lung disease. J Immunol (2001) 1.66
Overexpression of heat-shock proteins reduces survival of Mycobacterium tuberculosis in the chronic phase of infection. Nat Med (2001) 1.61
Derivation and biochemical characterization of an enterovirus group-specific monoclonal antibody. Intervirology (1987) 1.57
Photodynamic destruction of human bladder carcinoma. Br J Cancer (1975) 1.55
Cerebral photosensitisation by haematoporphyrin derivative. Evidence for an endothelial site of action. Br J Cancer (1986) 1.53
Characterization of IS1110, a highly mobile genetic element from Mycobacterium avium. Mol Microbiol (1994) 1.49
Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48
meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity. Br J Cancer (1986) 1.47
Dose-response curves for agents that impair cell reproductive integrity. A fundamental difference between dose-response curves of antimetabolites and those for radiation and alkylating agents. Br J Cancer (1969) 1.44
Photodynamic therapy with chlorins for diffuse malignant mesothelioma: initial clinical results. Br J Cancer (1991) 1.42
Cardiac and pulmonary effects of high doses of cyclophosphamide and isophosphamide. Cancer Res (1974) 1.36
Defect of macrophage function in the antibody response to sheep erythrocytes in systemic Mycobacterium lepraemurium infection. Nature (1975) 1.35
Depression of lymphocyte responses after surgical trauma. Br J Exp Pathol (1973) 1.29
Correlations between methods for measurement of synergy. J Infect Dis (1980) 1.29
Plasmid analysis of Mycobacterium avium-intracellulare (MAI) isolated in the United Kingdom from patients with and without AIDS. J Med Microbiol (1991) 1.27
The growth of human tumours in immunosuppressed mice and their response to chemotherapy. Br J Cancer (1974) 1.27
In vivo determination of the fractional kill of human tumor cells by chemotherapeutic agents. Cancer Chemother Rep (1972) 1.26
Immunity to malaria. 3. Possible occurrence of a cell-mediated immunity to Plasmodium knowlesi in chronically infected and Freund's complete adjuvant-sensitized monkeys. Exp Parasitol (1970) 1.24
Ribosomal internal transcribed spacer sequences are identical among Mycobacterium avium-intracellulare complex isolates from AIDS patients, but vary among isolates from elderly pulmonary disease patients. Microbiology (1995) 1.23
Cell respiration as a requirement for antibody release in vitro. Nature (1968) 1.21
Rapid methods for counting mycobacteria--comparison of methods for extraction of mycobacterial adenosine triphosphate (ATP) determined by firefly luciferase assay. Tubercle (1985) 1.21
Plasmodium berghei infections in thymectomized rats. Nature (1968) 1.20
Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J (1989) 1.19
Systemic Mycobacterium lepraemurium infection in mice: differences in doubling time in liver, spleen, and bone marrow, and a method for measuring the proportion of viable organisms in an inoculum. Infect Immun (1976) 1.14
Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability. Immunology (1979) 1.14
Synergistic effect of cortisol and prostaglandin E2 on the PHA response. Relation to immunosuppression induced by trauma. Clin Exp Immunol (1976) 1.11
Clinical and research application of an enterovirus group-reactive monoclonal antibody. Intervirology (1987) 1.05
Immunity to Plasmodium berghei in rats: passive serum transfer and role of the spleen. Infect Immun (1974) 1.04
The therapeutic significance of the dose response curve for antilymphocytic serum. Transplantation (1971) 1.02
The effect of microsomal enzyme inhibition on the immunosuppressive and toxic effects of cyclophosphamide. Clin Exp Immunol (1973) 1.01
Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity. J Pathol (1996) 1.01
Immunosuppression by L-asparaginase. Nature (1970) 0.99
Active suppression masks an underlying enhancement of antibody production in vitro by spleen cells from BCG-infected mice. Immunology (1980) 0.99
Clinical aspects of mycobacterial infections in HIV infection. Res Microbiol (1992) 0.99
Antibody response in vitro of spleen cells from Plasmodium yoelii-infected mice. Infect Immun (1977) 0.99
Genetic and serovar typing of clinical isolates of the Mycobacterium avium-intracellulare complex. Tuber Lung Dis (1996) 0.96
Bacille Calmette-Guérin (BCG)-associated inflammation and fibrosis: modulation by recombinant BCG expressing interferon-gamma (IFN-gamma). Clin Exp Immunol (2000) 0.95
The effect of oral Mycobacterium vaccae on subsequent responses of mice to BCG sensitization. Tubercle (1985) 0.95
Effects of L-asparaginase on lymphocyte-target cell reactions in vitro. Nature (1970) 0.95
The sensitivity to chemotherapeutic agents of a rat tumour grown in immunosuppressed mice. Br J Cancer (1971) 0.95
Interferon-gamma as an adjuvant in immunocompromised mice. Immunology (1989) 0.95
Synergy with double and triple antibiotic combinations compared. J Antimicrob Chemother (1983) 0.95
Wavelength and light-dose dependence in tumour phototherapy with haematoporphyrin derivative. Br J Cancer (1985) 0.94
Immunosuppressive agents: the design of selective therapeutic schedules. Antibiot Chemother (1969) 0.93
A modified broth dilution assay for antibiotic sensitivity testing of Mycobacterium avium-intracellulare using paraffin slide cultures. Tubercle (1991) 0.92
The rabbit VX2 tumour as a model for carcinomas of the tongue and larynx. Acta Otolaryngol (1989) 0.91
Synergy assessment with growth curves. J Infect Dis (1984) 0.90
Radiosensitivity of immunologically activated cells. Nature (1966) 0.89
Mycobacterium bovis, BCG, modulation of murine antibody responses: influence of dose and degree of aggregation of live or dead organisms. Br J Exp Pathol (1982) 0.89
Changes in murine bone marrow macrophages and erythroid burst-forming cells following the intravenous injection of liposome-encapsulated dichloromethylene diphosphonate (Cl2MDP). Eur J Haematol (2001) 0.89
Gastro-intestinal involvement in Mycobacterium avium-intracellulare infection of patients with HIV. J Infect (1993) 0.88
Minor synergy and antagonism may be clinically important. J Antimicrob Chemother (1987) 0.88
HPD - a study of its components and their properties. Adv Exp Med Biol (1983) 0.87
Selective suppression of murine antibody-dependent cell-mediated cytotoxicity by azathioprine. Transplantation (1975) 0.87
Blood-stage malaria in Biozzi high and low antibody responder mice: the importance of antibody and macrophages in immunity. Ann Immunol (Paris) (1984) 0.86
Enhancement of the antibody response in vitro by BCG. Dev Biol Stand (1978) 0.85
Mycobacterium vaccae and immune responses: implications for leprosy control. Lepr Rev (1985) 0.84
The localization of haemolytic antibody in sections of lymphoid organs: an improved method. Immunology (1970) 0.84
Synergy and antagonism are not synonymous with therapeutic advantage and disadvantage. J Antimicrob Chemother (1988) 0.84
Role of mitosis and mitotic inhibition in the immunosuppressive action of thioguanine. Nature (1966) 0.83
Macrophage functions in Biozzi mice. Immunology (1985) 0.83
Consequences of synergy between environmental carcinogens. Environ Res (1985) 0.82
BCG, Corynebacterium parvum or Mycobacterium leprae added to cultures of BCG-primed mouse spleen cells cause an enhanced primary antibody response in vitro. Immunology (1981) 0.82
Protective effects of a novel perfluorochemical emulsion in photodynamic therapy. Biomater Artif Cells Immobilization Biotechnol (1992) 0.82
Time-dependence and selectivity of immunosuppressive agents. Immunology (1979) 0.82
Macrophages are a major source of acetaldehyde in circulating acetaldehyde-albumin complexes formed after exposure of mice to ethanol. Alcohol Clin Exp Res (1994) 0.82
The effect of cysteine on the immunosuppressive activity of busulphan, cyclophosphamide and nitrogen mustard. Br J Cancer (1971) 0.82
Effect of some metabolic inhibitors on plaque formation in Jerne plates. Nature (1967) 0.81
Effect of cyclophosphamide on the homograft response in the guinea pig. Transplantation (1965) 0.81
Transplantation and immunosuppression. Mod Trends Immunol (1967) 0.81
The mode of action of cytotoxic drugs. Proc R Soc Med (1970) 0.80
Immunologically mediated macrophage aggregation in monolayers of peritoneal cells from BCG-sensitized mice. Immunology (1977) 0.80
Differential asparaginase sensitivity of T-cell and B-cell responses. Clin Exp Immunol (1973) 0.80
Enhancement of the antibody response in vitro by adherent cells from mice infected with Mycobacterium lepraemurium. Infect Immun (1977) 0.79
Defective antigen processing associated with familial disseminated mycobacteriosis. Clin Exp Immunol (1996) 0.79
Porphyrin sensitizers in tumour phototherapy. Novel sensitizers of the chlorin and bacteriochlorin class with amphiphilic properties. J Photochem Photobiol B (1990) 0.79
The effect of Kupffer cell elimination on ethanol-induced liver damage in mice. Int J Exp Pathol (1995) 0.79
Research ethics and deception. Lancet (1980) 0.78
Phagosome/lysosome fusion: a possible prerequisite for the enhancement of antibody responses in vitro by BCG, Mycobacterium leprae and Corynebacterium parvum. Parasite Immunol (1979) 0.78
Immunosuppressive agents: generation and consequences of differing dose-response curves. Proc R Soc Med (1972) 0.78
Letter: Predicting response of human cancer to chemotherapy. Lancet (1974) 0.78
Immunosuppression by platinum diamines. Br J Cancer (1971) 0.77
Intercellular immunological controls and modulation of cyclic AMP levels. Some doubts. Immunology (1976) 0.77